Grey matter and cognitive patterns in cognitive impaired subjects using CSF biomarker cut-offs

dc.contributor.author
Miralbell Blanch, Júlia
dc.contributor.author
Spulber, Gabriela
dc.contributor.author
Hooshmand, Babak
dc.contributor.author
Besga, Ariadna
dc.contributor.author
Mataró Serrat, Maria
dc.contributor.author
Cedazo-Mínguez, Ángel
dc.contributor.author
Kivipelto, Miia
dc.contributor.author
Wahlund, Lars-Olof
dc.date.accessioned
2026-01-27T05:17:57Z
dc.date.available
2026-01-27T05:17:57Z
dc.date.issued
2026-01-26T17:32:38Z
dc.date.issued
2026-01-26T17:32:38Z
dc.date.issued
2012
dc.date.issued
2026-01-26T17:32:38Z
dc.identifier
1387-2877
dc.identifier
https://hdl.handle.net/2445/226185
dc.identifier
605108
dc.identifier.uri
http://hdl.handle.net/2445/226185
dc.description.abstract
The aim of this study was to investigate brain tissue volumes, grey matter (GM) distribution, and cognitive performance for cognitively impaired subjects using cerebrospinal fluid (CSF) biomarker cut-offs as grouping criteria. 41 subjects attending the Memory Clinic, Karolinska University Hospital, Huddinge, Sweden, were divided into groups based on normal or abnormal CSF levels of Aβ1-42, t-tau, and p-tau181. SIENAX algorithms were employed for brain tissue volumes estimation and voxel-based morphometry (VBM) for mapping the differences in GM patterns. VBM revealed significant lower GM volumes in temporo-parietal, occipital, and prefrontal cortices for those subjects belonging to abnormal CSF t-tau and p-tau181 groups. No differences were found between groups according to CSF Aβ1-42 cut-offs. Patients with abnormal CSF p-tau181 showed lower cognitive performance compared to those with normal levels. Patients with abnormal levels of CSF tau (but not Aβ1-42) showed an Alzheimer's disease-like pattern for both GM distribution and cognitive profile, compared to those with normal levels. These results support the hypothesis that CSF t-tau or p-tau181 levels may be of direct value for the evaluation of disease severity.
dc.format
9 p.
dc.format
application/pdf
dc.language
eng
dc.publisher
IOS Press
dc.relation
Reproducció del document publicat a: https://doi.org/10.3233/JAD-2012-111553
dc.relation
Journal of Alzheimer's Disease, 2012, vol. 29, num.4, p. 741-749
dc.relation
https://doi.org/10.3233/JAD-2012-111553
dc.rights
(c) Miralbell, J. et al., 2012
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
Marcadors bioquímics
dc.subject
Trastorns de la cognició
dc.subject
Cervell
dc.subject
Biochemical markers
dc.subject
Cognition disorders
dc.subject
Brain
dc.title
Grey matter and cognitive patterns in cognitive impaired subjects using CSF biomarker cut-offs
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.